CClinicalTrials.gg
RecruitingNCT07366515Updated May 5, 2026

Feasibility of a Multimodal Virtual Reality Intervention to Reduce Preoperative Anxiety in Cancer Surgery Patients

An interventional study of Virtual Reality in Oncologic Surgery, sponsored by University of Manitoba. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-05-05.

Sponsored by University of Manitoba · Not applicable, Interventional, and Device feasibility

From the registry’s dates

  • Primary completion was expected by Jun 2026, 4 months ago, but the record still lists the study as recruiting.
  • Started Apr 2026; still recruiting 5 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this study is to assess the feasibility of an expanded virtual reality (VR) intervention designed to help prepare patients for cancer surgery. This study will: (1) assess the investigator's ability to recruit, retain, and engage participants, (2) evaluate how acceptable participants find the intervention through their feedback on its individual components. The investigators will also explore whether baseline anxiety levels or psychiatric history predict responses to the intervention, as well as look for any changes in perioperative anxiety and monitoring for any adverse effects associated with the intervention. This study will also investigate engagement of providing participants with a first-person VR session recordings to determine utility and whether post-session access is perceived as beneficial. Finally, preliminary pilot outcomes will examine whether increased engagement in the VR results in reductions in anxiety on the day of surgery.

02

Conditions studied

  • Oncologic Surgery

Keywords

  • virtual reality
  • oncological surgery
  • feasibility
  • perioperative mental health
  • preoperative anxiety and distress
03

In context

Lead sponsor

University of Manitoba is the lead sponsor of 542 studies on the registry; 87 are open to participants now.

Of its 12 completed or terminated interventional studies of FDA-regulated products, 5 (42%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Eligibility criteria

Patients will be deemed eligible for inclusion if they: (a) are 18 years of age or older; (b) are able to speak and read English; (c) have received a cancer diagnosis; and (d) are scheduled, or in the process of being scheduled to undergo oncological surgery under general anesthesia at the Health Sciences Centre Winnipeg. Patients will be deemed ineligible if they are unable to provide informed consent (e.g., due to cognitive impairment) or if they have any visual, auditory and/or motor impairments that would preclude effective participation in the Virtual Reality intervention.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
20 participants (estimated)

Study arms

  • Other
    Daily Viewing Group

    Participants assigned to this group will be instructed to review the standardized VR intervention recording daily, following their in-person session and continuing up to their scheduled surgery date.

    Device: Virtual Reality

  • Other
    Self-directed group

    Participants assigned to this group will be instructed to review the standardized VR intervention recording as little or as much as they would like, following their in-person session and continuing up to their scheduled surgery date.

    Device: Virtual Reality

Interventions

  • DeviceVirtual Reality

    The VR simulation involves the experience of prepping, waiting, receiving, and recovering from surgery at a large tertiary care centre in Central Canada. It is designed to prepare patients for cancer surgery by increasing familiarity with the hospital environment, providing the opportunity to "experience" restricted areas of the hospital that patients cannot access until the day of the surgery, and better understand the surgical process. The simulation was originally developed for a prior research project focused on breast cancer surgery and has since been adapted based on participant feedback. The intervention includes multiple modules that progress from an orientation to the hospital environment to more immersive, first-person surgical experiences.

06

What researchers measure

Primary outcomes

  1. Engagement

    Length of time in minutes participants spent engaging with the virtual reality and each of its components during the in-person session

    Time frame: Day 0 post-intervention

  2. Acceptability

    The Theoretical Framework of Acceptability Questionnaire (TFAQ score \> 3 indicates acceptability). Range 1-5 on seven items.

    Time frame: Day 0 post-intervention

Secondary outcomes

  1. Anxiety

    Generalized Anxiety Disorder 7. Range 0 to 21, higher score = higher anxiety.

    Time frame: Baseline

  2. Depression

    Patient Health Questionnaire-8 (PHQ-8). Range 0 to 24, higher score = higher depressive symptoms.

    Time frame: Baseline

  3. Pre-Operative Anxiety

    Amsterdam Preoperative Anxiety and Information Scale (APAIS). Range 4 - 30 for 6 items.

    Time frame: Baseline and re-administered pre-operatively on the day of surgery

  4. Pre-Operative Anxiety

    Pre-operative Intrusive Thoughts Inventory (PITI). Range 0 to 60 on 20 items, score \>15 indicative of clinically significant preoperative anxiety.

    Time frame: Baseline

  5. Pre-Operative Anxiety

    National Comprehensive Cancer Network (NCCN) Anxiety Thermometer. A brief self-report visual analogue scale (VAS) for anxiety. Range 0 to 10, higher score = higher anxiety

    Time frame: Baseline and re-administered pre-operatively on the day of surgery.

  6. Pre-Operative Distress

    NCCN Distress Thermometer. A brief self-report visual analogue scale (VAS) for anxiety. Range 0 to 10, higher score = higher distress.

    Time frame: Baseline and re-administered pre-operatively on the day of surgery

  7. Cybersickness

    Simulator Sickness Questionnaire. Range 0-3 for each 16 items, higher score = more severe symptoms.

    Time frame: Day 0 post-intervention

  8. Presence

    iGroup Presence Questionnaire. Range -3 to +3 for each of 14 items, higher score = higher presence.

    Time frame: Day 0 post-intervention

  9. Perceived Usability of Device

    System Usability Scale. Range 1 to 5 for each of 10 items, higher score = better usability

    Time frame: Day 0 post-intervention

  10. Engagement & Adherence - Standardized Video

    Length of time in minutes that the participant engaged with the standardized video, and whether this aligned with the instructions provided.

    Time frame: Day 1 up to Day 14

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No — Individual participant data will not be shared, consistent with common practice in feasibility studies.

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07366515
Lead sponsor
University of Manitoba
Responsible party
Renée El-Gabalawy (Associate Professor & Clinical Psychologist, University of Manitoba) — Principal investigator
First posted
Jan 26, 2026
Start date
Apr 22, 2026
Primary completion
Jun 1, 2026 (estimated)
Completion
Jun 30, 2026 (estimated)
Last update
May 5, 2026

Study contacts

Cassidy Santos, BA (Hons.)
Contact
csantos17@hsc.mb.ca
204-787-7424
Renee El-Gabalawy, PhD
Contact
renee.el-gabalawy@umanitoba.ca
204-787-4083
Renee El-Gabalawy, PhD
principal investigator · University of Manitoba

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion